Cidara Therapeutics, Inc.

NasdaqCM:CDTX 株式レポート

時価総額：US$143.8m

Cidara Therapeutics マネジメント

マネジメント 基準チェック /24

Cidara Therapeuticsの CEO はJeff Steinで、 Jan2014年に任命され、 の在任期間は 10.83年です。 の年間総報酬は$ 1.56Mで、 38.1%給与と61.9%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の1.03%を直接所有しており、その価値は$ 1.48M 。経営陣と取締役会の平均在任期間はそれぞれ3.5年と3.8年です。

主要情報

Jeff Stein

最高経営責任者

US$1.6m

報酬総額

CEO給与比率38.1%
CEO在任期間10.8yrs
CEOの所有権1.0%
経営陣の平均在職期間3.5yrs
取締役会の平均在任期間3.8yrs

経営陣の近況

Recent updates

We Think Cidara Therapeutics (NASDAQ:CDTX) Can Easily Afford To Drive Business Growth

Sep 28
We Think Cidara Therapeutics (NASDAQ:CDTX) Can Easily Afford To Drive Business Growth

Lacklustre Performance Is Driving Cidara Therapeutics, Inc.'s (NASDAQ:CDTX) 39% Price Drop

Apr 17
Lacklustre Performance Is Driving Cidara Therapeutics, Inc.'s (NASDAQ:CDTX) 39% Price Drop

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Analysts Are Reducing Their Forecasts For This Year

Mar 25
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Analysts Are Reducing Their Forecasts For This Year

We're Hopeful That Cidara Therapeutics (NASDAQ:CDTX) Will Use Its Cash Wisely

Mar 14
We're Hopeful That Cidara Therapeutics (NASDAQ:CDTX) Will Use Its Cash Wisely

Cidara spikes on $11M milestone payment from partner Mundipharma

Oct 04

Cidara begins dosing of antiviral CD388 in trial for preventing influenza

Sep 13

Cidara Therapeutics GAAP EPS of -$0.19 beats by $0.09, revenue of $6.22M beats by $0.01M

Aug 09

Industry Analysts Just Made A Captivating Upgrade To Their Cidara Therapeutics, Inc. (NASDAQ:CDTX) Revenue Forecasts

Dec 17
Industry Analysts Just Made A Captivating Upgrade To Their Cidara Therapeutics, Inc. (NASDAQ:CDTX) Revenue Forecasts

Rainbows and Unicorns: Cidara Therapeutics, Inc. (NASDAQ:CDTX) Analysts Just Became A Lot More Optimistic

Aug 17
Rainbows and Unicorns: Cidara Therapeutics, Inc. (NASDAQ:CDTX) Analysts Just Became A Lot More Optimistic

Is Cidara Therapeutics (NASDAQ:CDTX) Weighed On By Its Debt Load?

Aug 04
Is Cidara Therapeutics (NASDAQ:CDTX) Weighed On By Its Debt Load?

Cidara Therapeutics: Rezafungin Data Could Bring Value

Jul 20

CEO報酬分析

Cidara Therapeutics の収益と比較して、Jeff Stein の報酬はどのように変化したか？
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$124m

Jun 30 2024n/an/a

-US$112m

Mar 31 2024n/an/a

-US$24m

Dec 31 2023US$2mUS$594k

-US$23m

Sep 30 2023n/an/a

-US$34m

Jun 30 2023n/an/a

-US$18m

Mar 31 2023n/an/a

-US$22m

Dec 31 2022US$1mUS$566k

-US$34m

Sep 30 2022n/an/a

-US$33m

Jun 30 2022n/an/a

-US$63m

Mar 31 2022n/an/a

-US$44m

Dec 31 2021US$2mUS$566k

-US$42m

Sep 30 2021n/an/a

-US$47m

Jun 30 2021n/an/a

-US$47m

Mar 31 2021n/an/a

-US$74m

Dec 31 2020US$1mUS$542k

-US$75m

Sep 30 2020n/an/a

-US$67m

Jun 30 2020n/an/a

-US$47m

Mar 31 2020n/an/a

-US$42m

Dec 31 2019US$1mUS$526k

-US$41m

Sep 30 2019n/an/a

-US$39m

Jun 30 2019n/an/a

-US$56m

Mar 31 2019n/an/a

-US$69m

Dec 31 2018US$1mUS$501k

-US$69m

Sep 30 2018n/an/a

-US$70m

Jun 30 2018n/an/a

-US$69m

Mar 31 2018n/an/a

-US$59m

Dec 31 2017US$2mUS$460k

-US$56m

報酬と市場: Jeffの 総報酬 ($USD 1.56M ) は、 US市場 ($USD 647.72K ) の同規模の企業の平均を上回っています。

報酬と収益: Jeffの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Jeff Stein (69 yo)

10.8yrs

在職期間

US$1,558,544

報酬

Dr. Jeffrey L. Stein, Ph D., also known as Jeff, has been the Chief Executive Officer, President and Executive Director of Cidara Therapeutics, Inc. since January 2014. Dr. Stein served as Principal Financ...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Jeffrey Stein
President10.8yrsUS$1.56m1.03%
$ 1.5m
Shane Ward
COO & Corporate Secretary3.3yrsUS$929.86k0.073%
$ 104.8k
Taylor Sandison
Chief Medical Officer8.2yrsUS$884.09k0.18%
$ 261.1k
Kevin Forrest
Founder & Chief Strategy Officerno dataUS$613.24kデータなし
Preetam Shah
CFO & Principal Accounting Officer3.2yrsUS$683.71k0.11%
$ 153.3k
Allison Lewis
Senior Vice President of People & Culture3.8yrsデータなしデータなし
Leslie Tari
Chief Scientific Officer5.7yrsUS$1.39m0.12%
$ 171.9k
Nicole Davarpanah
Senior VP of Translational Research & Development1.3yrsデータなしデータなし
Jim Beitel
Chief Business Officerless than a yearデータなしデータなし

3.5yrs

平均在職期間

51.5yo

平均年齢

経験豊富な経営陣: CDTXの経営陣は 経験豊富 であると考えられます ( 3.5年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Jeffrey Stein
President10.8yrsUS$1.56m1.03%
$ 1.5m
Daniel Burgess
Independent Chairman of the Board10.6yrsUS$126.84k0.0021%
$ 3.1k
Theodore Schroeder
Independent Director10.6yrsUS$98.84k0%
$ 0
Frederick Hayden
Member of the Scientific Advisory Board4.3yrsデータなしデータなし
Bonnie Bassler
Independent Director3.8yrsUS$86.84k0.00021%
$ 301.9
Carin Canale-Theakston
Independent Director3.8yrsUS$82.34k0%
$ 0
Chrysa Mineo
Independent Director6.7yrsUS$91.34k0%
$ 0
Ryan Spencer
Independent Directorless than a yearデータなしデータなし
James Merson
Independent Directorless than a yearデータなしデータなし
Laura Tadvalkar
Independent Directorless than a yearデータなしデータなし
Mario Barro
Member of Scientific Advisory Boardless than a yearデータなしデータなし
Philip Krause
Member of Scientific Advisory Boardless than a yearデータなしデータなし

3.8yrs

平均在職期間

62yo

平均年齢

経験豊富なボード: CDTXの 取締役会 は 経験豊富 であると考えられます ( 3.8年の平均在任期間)。